Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of the local hemodynamic environment on the de novo development and progression of eccentric coronary atherosclerosis in humans: insights from PREDICTION.
Papafaklis MI, Takahashi S, Antoniadis AP, Coskun AU, Tsuda M, Mizuno S, Andreou I, Nakamura S, Makita Y, Hirohata A, Saito S, Feldman CL, Stone PH. Papafaklis MI, et al. Among authors: hirohata a. Atherosclerosis. 2015 May;240(1):205-11. doi: 10.1016/j.atherosclerosis.2015.03.017. Epub 2015 Mar 16. Atherosclerosis. 2015. PMID: 25801012
Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial.
Hirohata A, Yamamoto K, Miyoshi T, Hatanaka K, Hirohata S, Yamawaki H, Komatsubara I, Hirose E, Kobayashi Y, Ohkawa K, Ohara M, Takafuji H, Sano F, Toyama Y, Kusachi S, Ohe T, Ito H. Hirohata A, et al. Among authors: hirohata s. Atherosclerosis. 2012 Jan;220(1):134-8. doi: 10.1016/j.atherosclerosis.2011.10.013. Epub 2011 Nov 9. Atherosclerosis. 2012. PMID: 22119063 Clinical Trial.
Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION Study.
Stone PH, Saito S, Takahashi S, Makita Y, Nakamura S, Kawasaki T, Takahashi A, Katsuki T, Nakamura S, Namiki A, Hirohata A, Matsumura T, Yamazaki S, Yokoi H, Tanaka S, Otsuji S, Yoshimachi F, Honye J, Harwood D, Reitman M, Coskun AU, Papafaklis MI, Feldman CL; PREDICTION Investigators. Stone PH, et al. Among authors: hirohata a. Circulation. 2012 Jul 10;126(2):172-81. doi: 10.1161/CIRCULATIONAHA.112.096438. Epub 2012 Jun 21. Circulation. 2012. PMID: 22723305
Response to Letter Regarding Article, “Prediction of Progression of Coronary Artery Disease and Clinical Outcomes Using Vascular Profiling of Endothelial Shear Stress and Arterial Plaque Characteristics: The PREDICTION Study”.
Makita Y, Nakamura S, Kawasaki T, Takahashi A, Katsuki T, Nakamura S, Namiki A, Hirohata A, Matsumura T, Yamazaki S, Yokoi H, Tanaka S, Otsuji S, Yoshimachi F, Honye J, Harwood D, Reitman M, Coskun AU, Papafaklis MI, Feldman CL. Makita Y, et al. Among authors: hirohata a. Circulation. 2013 Mar 12;127(10):e489-90. doi: 10.1161/circulationaha.112.147561. Circulation. 2013. PMID: 23599923 No abstract available.
Changes in coronary anatomy and physiology after heart transplantation.
Hirohata A, Nakamura M, Waseda K, Honda Y, Lee DP, Vagelos RH, Hunt SA, Valantine HA, Yock PG, Fitzgerald PJ, Yeung AC, Fearon WF. Hirohata A, et al. Am J Cardiol. 2007 Jun 1;99(11):1603-7. doi: 10.1016/j.amjcard.2007.01.039. Epub 2007 Apr 19. Am J Cardiol. 2007. PMID: 17531589 Free PMC article.
Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
Hirohata A, Yamamoto K, Miyoshi T, Hatanaka K, Hirohata S, Yamawaki H, Komatsubara I, Murakami M, Hirose E, Sato S, Ohkawa K, Ishizawa M, Yamaji H, Kawamura H, Kusachi S, Murakami T, Hina K, Ohe T. Hirohata A, et al. Among authors: hirohata s. J Am Coll Cardiol. 2010 Mar 9;55(10):976-82. doi: 10.1016/j.jacc.2009.09.062. J Am Coll Cardiol. 2010. PMID: 20202514 Free article. Clinical Trial.
Olmesartan reduces inflammatory biomarkers in patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the OLIVUS trial.
Miyoshi T, Hirohata A, Usui S, Yamamoto K, Murakami T, Komatsubara I, Kusachi S, Ohe T, Nakamura K, Ito H. Miyoshi T, et al. Among authors: hirohata a. Heart Vessels. 2014 Mar;29(2):178-85. doi: 10.1007/s00380-013-0343-0. Epub 2013 Apr 7. Heart Vessels. 2014. PMID: 23563752 Clinical Trial.
127 results